Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Arrow Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (162)
Cancellation or suspension (56)
Prescription medicine registration (4)
Listed medicine compliance report (1)
Section 14, TGO91 consent (1)

Date

2024 (8)
2023 (32)
2022 (84)
2021 (40)
2020 (11)
2019 (23)
2018 (24)
2017 (2)

Results for "[search-keyword]"

Search

Sponsor content

224 result(s) found, displaying 191 to 200

ATOMERRA atomoxetine (as hydrochloride) 25 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2019

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
ATOMERRA atomoxetine (as hydrochloride) 40 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2019

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
ATOMERRA atomoxetine (as hydrochloride) 80 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2019

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
CHEMISTS' OWN PAIN TABLETS bottle (reformulation) Cancelled under Section 30(1)(c) of the Act

24 June 2019

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
KOSTEO calcitriol 0.25 microgram capsule bottle Cancelled under Section 30(1)(c) of the Act

24 June 2019

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
TENSIG atenolol 50mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

20 June 2019

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
PREGABALIN ARW, PREGABALIN CW, PREGABALIN TIH (Arrow Pharma Pty Ltd)

14 June 2019

Prescription medicine registration

Active ingredients: pregabalin.
OXYBUTYNIN ARW, OXYBUTYNIN TIH, OXYBUPAN (Arrow Pharma Pty Ltd)

18 March 2019

Prescription medicine registration

Active ingredients: oxybutynin hydrochloride.
Rabeprazole ARW rabeprazole sodium 10mg enteric-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

21 June 2018

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
Rabeprazole ARW rabeprazole sodium 20mg enteric-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

21 June 2018

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd

Pages

First page
Previous page
…
Page 15
Page 16
Page 17
Page 18
Page 19
Current page 20
Page 21
Page 22
Page 23
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.